UGenome AI
Healthcare Software · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.ugenome.ioRevenue
<$5 MillionIndustry
About UGenome AI
UGenome AI Org Chart
Is UGenome AI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at UGenome AI
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once UGenome AI has new funding data
Product Launch: Get notified when UGenome AI launches new products
UGenome AI, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on UGenome AI recently announced quarterly report
Check if UGenome AI has recently received funding, and reach out quickly before it becomes old news!
Check out if UGenome AI is spiking on competitors!
Click to see if UGenome AI had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
UGenome AI is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
UGenome AI is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about UGenome AI.
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding UGenome AI
UGenome is a genomic software company dedicated to transforming personal healthcare through innovative bioinformatics solutions. They provide tools that turn complex biological data into actionable insights, empowering individuals and organizations to unlock the potential of their DNA. UGenome focuses on making genomic medicine personal and accessi... Read More